AtomVie Global Radiopharma raises over $90M to complete its new facility buildout

OBIO NewsOntario Industry Updates
Written By Arsheen Kaur

AtomVie Global Radiopharma Inc. (AtomVie), a global-leading Contract Development and Manufacturing Organization (CDMO) for the GMP manufacturing and worldwide distribution of radiopharmaceuticals, recently announced the closing of its Tranche 2 Series A financing, reaching over $90M total to complete building its new state-of-the-art GMP manufacturing facility.

Atomvie Global is an OBIO® member.

Arsheen Kaur
Previous

Fluid Biomed Inc. announces world's first implantation of polymer-based neurovascular stent in human patients
Next

Able Innovations joins Mayo Clinic Innovation Exchange